Crystalline hydrates of 1-(b-D-glucopyranosyl)-4-methyl-3-[5-(4-fluorophenyl)-2-thienylmethyl]benzene | Patent Number 10323056

US 10323056 B2
Application Number14888961
Publication NumberUS 20160145286 A1
Pendency5 years, 1 month, 13 days
Filled DateMay 7, 2014
Priority DateMay 7, 2014
Publication DateMay 26, 2016
Expiration DateMay 6, 2034
Inventor/ApplicantsAndreas Hotter
Ulrich Griesser
Christoph Langes
Lovro Selic
ExaminesOLSON, ERIC
Art Unit1623
Technology Center1600
Assignments
Lek Pharmaceuticals D.d. Sandoz
Current
Lek Pharmaceuticals D.d. SandozNovartis
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.